Treatment of Metastasis in the Appendicular Skeleton

Abstract

Bone metastases may evolve with events (pain, fractures and compression) that the orthopedic surgeon will encounter regardless of his subspecialty. Accumulated surgical knowledge is predictive for the prevention of impending fractures, as well as of pathological fractures. We will present a guide to properly evaluate and conduct a patient with bone implant for surgeons who are not specialists in this area.

Keywords

bone neoplasms - metastases - fractures, pathologic/surgery - carcinoma

Publication History

Received: 16 December 2019

Accepted: 17 December 2020

Article published online:
27 May 2022

• Referências

• 1 Laitinen M, Ratasvuori M, Pakarinen TK. The multi-modal approach to metastatic diseases. In: Bentley G. editor. European Intructional Lectures. Berlin, Heidelberg: Springer; 2012: 35-44
• 2 Kelly M, Lee M, Clarkson P, O'Brien PJ. Metastatic disease of the long bones: a review of the health care burden in a major trauma centre. Can J Surg 2012; 55 (02) 95-98
• 3 Yong C, Onukwugha E, Mullins CD. Clinical and economic burden of bone metastasis and skeletal-related events in prostate cancer. Curr Opin Oncol 2014; 26 (03) 274-283
• 4 Brodowicz T, Hadji P, Niepel D, Diel I. Early identification and intervention matters: A comprehensive review of current evidence and recommendations for the monitoring of bone health in patients with cancer. Cancer Treat Rev 2017; 61: 23-34
• 5 Bochtler T, Krämer A. Does Cancer of Unknown Primary (CUP) Truly Exist as a Distinct Cancer Entity?. Front Oncol 2019; 9: 402
• 6 Jesus-Garcia R, Moura M, Granata Junior GS. et al. Metástase de Origem Primária desconhecida: primeira manifestação no tecido ósseo. Rev Bras Ortop 1996; 31 (11) 641-646
• 7 Morley N, Omar I. Imaging evaluation of musculoskeletal tumors. New York: Springer; 2014: 9-29
• 8 Avedian RS. Principles of musculoskeletal biopsy. Cancer Treat Res 2014; 162: 1-7
• 9 Lutz S, Berk L, Chang E. et al; American Society for Radiation Oncology (ASTRO). Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline. Int J Radiat Oncol Biol Phys 2011; 79 (04) 965-976
• 10 Teixeira S, Branco L, Fernandes MH, Costa-Rodrigues J. Bisphosphonates and Cancer: A Relationship Beyond the Antiresorptive Effects. Mini Rev Med Chem 2019; 19 (12) 988-998
• 11 Mirels H. Metastatic disease in long bones. A proposed scoring system for diagnosing impending pathologic fractures. Clin Orthop Relat Res 1989; (249) 256-264
• 12 Simmons CPL, McMillan DC, McWilliams K. et al. Prognostic Tools in Patients With Advanced Cancer: A Systematic Review. J Pain Symptom Manage 2017; 53 (05) 962-970.e10
• 13 Soeharno H, Povegliano L, Choong PF. Multimodal Treatment of Bone Metastasis-A Surgical Perspective. Front Endocrinol (Lausanne) 2018; 9: 518
• 14 Jehn CF, Diel IJ, Overkamp F. et al. Management of Metastatic Bone Disease Algorithms for Diagnostics and Treatment. Anticancer Res 2016; 36 (06) 2631-2637
• 15 Narazaki DK, de Alverga Neto CC, Baptista AM, Caiero MT, de Camargo OP. Prognostic factors in pathologic fractures secondary to metastatic tumors. Clinics (São Paulo) 2006; 61 (04) 313-320
• 16 Moura M, Camargo OP. Iliotibial Tract Flap for Proximal Femur Tumor Replacemented by Megaprosthesis - Walking Without Claudication or Supports. In: 20th ISOLS General Meeting of the International Society of Limb Salvage, Athens, Greece. 2019
• 17 Errani C, Mavrogenis AF, Cevolani L. et al. Treatment for long bone metastases based on a systematic literature review. Eur J Orthop Surg Traumatol 2017; 27 (02) 205-211